Background and aim. Neonatal sepsis is a signi cant contributor to morbidity and mortality globally. Blood culture is the most reliable method for detection of bacterial infection. However, its sensitivity is low and its use in the diagnosis of bacteraemia is fraught with di culties. CD64 antigen is up-regulated in neutrophils only when they are activated, and has been shown to be a potential biomarker for infection. e primary objective of this study was quantitation of neutrophil CD64 by ow cytometry in neonates with signs and symptoms suggestive of sepsis/infection in the rst 4 weeks of life. Methods and results. In this prospective observational study, patients were classi ed into categories of infection, namely de nite, probable and possible. Of 76 neonates, 1 had de nite infection, 5 probable infection, 30 possible infection, and 32 no infection. e neutrophil CD64 index at a cut-o value of 1.8 had a high negative predictive value (95.2%) in ruling out combined probable and de nite infection. Conclusions. We recommend inclusion of the neutrophil CD64 index into the diagnostic algorithm for neonatal sepsis, as it has a high negative predictive value and can be used to rule out infection. As the positive predictive value of the index was low in con rming infection, it should be used as a screening rather than a con rmatory test.
Neonatal sepsis remains a global health problem owing to its significant contribution to morbidity and mortality. [1] [2] [3] Its early diagnosis presents a clinical dilemma because of varied and nonspecific clinical presentation. [1, [4] [5] [6] Microbiological cultures are currently used as the gold standard for diagnosis of infection/ sepsis and help in decision-making, especially in choosing the appropriate antibiotics. [2, 7, 8] However, the method is fraught with difficulties, including delay in final culture results (2 -4 days), negative culture results in patients exposed to antibiotics, and timing and technique of specimen collection. [2] [3] [4] [5] [6] [7] [8] Despite being widely acknowledged as lacking specificity and sensitivity, the white cell count (WCC), platelet count (Plt) and white cell differential count (Diff ) are still used for the screening of neonates with sepsis. [2, 9] Acute-phase reactants are also frequently used in predicting neonatal sepsis. [5, 6, 10] The most extensively used acute-phase reactant is C-reactive protein (CRP). [11] In a recent meta-analysis the sensitivity of this test was estimated to be 80%, but the specificity was only 60 -80%. [9] Several studies agree that serial measurements of CRP can guide the duration of antibiotic treatment in neonates managed for suspected sepsis before the final blood culture results are available. [3, 6, 11, 12] One of the newer acute-phase markers of infection is procalcitonin (PCT), the prohormone of calcitonin, which occurs in very low concentrations in the serum of healthy people. [5] PCT is claimed to be more specific for bacterial infections than viral infections, but it is not universally accepted as an improved diagnostic assay of infection. [13] Recently various investigators have focused their research on the diagnostic and clinical utility of neutrophil CD64 as a marker of sepsis or systemic infection in neonates [1, 4, 7, 14] and adults. [13, 15, 16] CD64 is a 72 kDa glycoprotein, known as FC gamma receptor I (FcγRI), that binds immunoglobulin G with high a nity. [17] CD64 is constitutively expressed on monocytes and various types of macrophages, but only to a very low extent on resting neutrophils. [9, 17] During neutrophil activation, under the in uence of in ammatory cytokines (interleukin-12, interferon gamma and granulocyte colony-stimulating factor), there is upregulation of neutrophil CD64. [13] Multiple studies agree that neutrophil CD64 has high diagnostic speci city and sensitivity. [13, [18] [19] [20] In the light of the above information, we prospectively evaluated the usefulness of neutrophil CD64 expression in diagnosing neonatal infection.
e main objective of the study was quantitation of neutrophil CD64 by ow cytometry in all neonates with signs and symptoms RESEARCH suggestive of sepsis/infection within the rst 4 weeks of life. 
Material and methods

Research
Inclusion criteria and study de nitions
All neonates (days 1 -28) suspected of having infection/sepsis by their treating clinician were eligible for enrolment in the study. Infection was suspected when nonspeci c signs and symptoms including respiratory distress, tachypnoea, tachycardia, hypoglycaemia and hyperglycaemia were present, or when there were maternal risk factors.
Neonates with severe congenital or chromosomal abnormalities were excluded from the study. e septic work-up was done at the clinician's discretion, but the full blood count (FBC), Di (not performed for every patient), CRP level and blood culture were all recorded for the purposes of the study. e CRP level was measured on the second day (after 24 -48 hours of suspicion of sepsis), while other tests were done on the rst day of suspicion of sepsis.
Neonates who had been on antibiotics for 48 hours or more, but clinically appeared septic and needed re-evaluation (another septic work-up), were also included in the study.
Categories of infection
Categories of infection were de ned using previously published criteria: [6] • Contamination. Positive microbiological cultures with less than three signs and symptoms of infection and normal WCC, Di , Plt and CRP.
• Possible infection. One or more of abnormal Plt, WCC, Di or CRP with negative microbiological cultures and less than three signs or symptoms of infection.
• Probable infection. One or more of abnormal Plt, WCC, CRP or Di with negative microbiological cultures with three or more signs or symptoms of infection.
• De nite infection. Positive microbiological cultures with any clinical signs or symptoms of infection and one or more of abnormal WCC, Di , Plt or CRP.
• No infection. Normal CRP, WCC, Di and Plt with negative microbiological cultures and less than three symptoms or signs of infection.
• Unclassi ed. Do not t into any of the other categories. In this study, however, Di was not used to categorise infection, as this test was not done in the majority of the patients.
Sample collection and storage
e attending paediatrician collected an additional tube of 0.3 ml peripheral blood (purple top with ethylenediaminetetra-acetic acid (EDTA), anticoagulant) for the purposes of this study concurrently with the other septic work-up blood investigations. is blood was stored at 4°C until informed consent was obtained from the parents for participation in the study. If consent was not obtained, the blood was discarded. Samples were processed within 48 hours of the blood being drawn, as per the manufacturer's guidelines.
Clinicians were unaware of the neutrophil CD64 results.
Collation of clinical and laboratory data
e clinical history was retrieved from the hospital medical les, both neonatal and maternal. Available laboratory results were retrieved from the laboratory information system: FBC, Di and blood culture at the time of the septic workup and CRP the next day.
Quantitation of neutrophil/polymorphonuclear cell (PMN) CD64
e Leuko64 kit (Trillium Diagnostics, LLC, ME, USA) is composed of antibodies with speci cities to CD64 (clones 22 and 32.2, both uorescein isothiocyanate conjugated) and to CD163 (clone Mac2-148, phycoerythrin conjugated), and a uorescent bead suspension. e sample preparation and ow cytometry setup was based on the manufacturer's instructions. [21] Brie y, 50 µl of whole blood was incubated for 15 minutes in the dark at room temperature with a mixture of the monoclonal antibodies followed by red cell lysis with ammonium chloride-based red cell lysis solution. Fluorescent beads were then added and ow cytometry analysis performed on the LSRII ow cytometer (Becton-Dickson, San Jose, CA) using FACSDIVA software. e CD64 index calculation was performed by Leuko64 QuantiCALC software (Trillium Diagnostics). An internal negative control was provided by the automated measurement of the lymphocyte CD64 index, and an internal positive control was provided by automated measurement of the monocyte CD64 index.
Statistical analysis
Stata 10.0 software was used to analyse data from a total of 76 neonates. Normality of data was tested using the Shapiro-Wilk test. Birth weight of participants, PMN CD64 and WCC showed a positively skewed distribution. Descriptive statistics for categorical (frequency and percentages) and continuous variables (median) were reported. Logistic regression models were used to determine the association between selected neonatal factors (gender and birth weight) and infection. e logistic model considered infection (blood culture positive) as the outcome variable of interest and neonatal factors as independent factors. Logistic regression models were also used to determine the association between selected neonatal factors (gender, gestational age and birth weight) and PMN CD64. Abnormal PMN CD64, i.e. >1.8, [21] was considered as the outcome of interest with the selected neonatal factors as independent variables. Receiver operating characteristic (ROC) curves were generated for PMN CD64 at various cut-o s by plotting sensitivity versus 1-speci city (speci city is the true-negative rate, that is the probability that a test result will be negative when the disease is not present; 1-speci city is the false- 
Results
Study population
e total number of neonates screened was 141, and 76 participants met the inclusion criteria.
Patient characteristics
According to the clinical ndings and blood culture results, patients were classi ed into categories of infection as de ned in 'Categories of infection' above. e number of participants nally assigned to each category was as follows: de nite infection (1), probable infection (5), possible infection (30), no infection (32), unclassi ed (8). Table 1 shows the demographic data.
e neonate who had de nite infection (positive blood culture) was female, preterm, and of very low birth weight (890 g). She was delivered by caesarean section and was 4 days old at the time of enrolment. Blood culture was positive for Gram-negative bacilli (Klebsiella pneumoniae, extendedspectrum beta-lactamase producer). Her CRP level was 29.0 mg/l and her PMN CD64 index 3.70.
e most frequent clinical sign in the study was respiratory distress (92.1%, 70/76), followed by tachypnoea (19.7%, 15/76). Other signs and symptoms included hypoglycaemia (6.6%, 5/76), tachycardia (3.9%, 3/76), hypothermia (2.6%, 2/76), failure to wean from oxygen (2.6%, 2/76) and hyperglycaemia (1.3%, 1/76). Fig. 1 illustrates PMN CD64 values in each category of infection, and Table 2 summarises the participants' blood results. According to the PMN CD64 index classi ed as normal (<1.8) versus high (>1.8), PMN CD64 was not statistically associated with gender, birth weight or gestational age.
Receiver operating characteristic analysis
e ROC curve is a graphical presentation of trade-o between sensitivity and speci city. e greater the area under the ROC curve (AUC), the more discriminatory the test is. e AUC measures the overall ability of the test (continuous variable) to discriminate between individuals with and without disease. In this study, ROC curves were done to compare PMN CD64 with the current gold standard test for diagnosis of infection and sepsis (blood culture). In addition, the performance of the PMN CD64 was also compared with our infection categories, using them as the gold standard. ROC curves were done at three di erent cut-o values of PMN CD64 index (1.6, 1.8 and 2.0). Fig. 2 shows the ROC curve of PMN CD64 at a cut-o value of 1.8 versus de nite and probable infection. Tables 3 and 4 show the summary of the sensitivity, speci city, positive predictive value (PPV), negative predictive value (NPV), 95% con dence interval (CI) and AUC values at various cut-o values for PMN CD64 in di erent categories of infection. 
Fig. 2. ROC curve of PMN CD64 at a cut-o value of 1.8 versus de nite and probable infection.
RESEARCH Discussion e diagnosis of neonatal sepsis is a challenge, as there is no single reliable test for its early con rmation or exclusion. [2, 6] An early biomarker of bacterial infection with high diagnostic sensitivity and speci city would be a valuable tool for therapeutic decision making, enabling unnecessary use of antibiotics in patients clinically suspected to have infection to be avoided. [7, 22, 23] Currently blood culture is the most reliable method for detection of bacterial infections. However, the sensitivity of this method is low and using it as a gold standard in the diagnosis of bacteraemia is fraught with di culties. [2, 10] A study by Magudumana et al. [6] showed that fewer than 10% of neonates evaluated and treated for sepsis had blood culture-con rmed infection.
In this study we evaluated the diagnostic utility of PMN CD64 in neonatal sepsis. Of 76 participants suspected to have sepsis because of clinical signs, only 1 had a positive blood culture. An additional 5 patients had probable infection and further 30 had possible infection according to de ned categories of infection. In neonatal sepsis a negative blood culture does not necessarily rule out infection. Using the patient group with both de nite and probable infection as the gold standard-positive group, PMN CD64 at a cut-o of 1.8 showed speci city of 60.6%, sensitivity of 85.7%, a PPV of 31.6% and an NPV of 95.2%. is is the patient group that probably represents the true-positive group, and the high NPV of PMN CD64 in this group indicates that PMN CD64 should nd a role in ruling out sepsis/infection when the PMN CD64 index is within the normal reference range. We believe that some of this group of babies had infection/sepsis despite negative blood cultures. As noted in the literature, there are multiple reasons for negative blood cultures, including possible e ects of antibiotic therapy in utero. [1] Our findings concur with the outcomes of numerous studies on the diagnostic performance of PMN CD64 in sepsis in view of the high sensitivity compared with blood culture and the high NPV. [13, 15, 16, 19] Most of these studies, however, report high PPVs, which do not concur with our findings. The reason for the low PPV in our study could be the fact that ours was a prospective analysis that did not start off with patients who had proven infection. As a result, we had a lower prevalence of blood culture-confirmed infection compared with retrospective cohort analyses.
If the patients with possible infection are included with the de nite and probable infection groups as the gold standard-positive group (1.8 cut-o ), the sensitivity of PMN CD64 in the diagnosis of infection decreases without an improvement in speci city. e PPV improved from 32% to 58.1%, but the NPV dropped to 51%. is is not, however, the most likely representation of the true-positive patient group, as if all patients with 'possible' infection were really in need of antibiotics for microbial sepsis, there would be no need for laboratory diagnostic markers of infection, and clinical suspicion would su ce, a scenario not true of daily clinical practice.
While our study was conducted mainly in neonates with early-onset infection, a study by Ng et al. in neonates with late-onset infection showed that PMN CD64 had the highest sensitivity and speci city at the onset of suspected infection (95% and 88%, respectively) and at 24 hours (97% and 90%). [4] In the same study, PMN CD64 had the best overall performance compared with CRP, interleukin-6, CD11b, CD25 and CD45RO.
In our study there was no statistically signi cant correlation between PMN CD64 and other markers of infection (CRP, WCC and Plt).
is suggests that CD64 is not supplying redundant information already given by CRP, WCC and Plt, but represents an independent variable with additional clinical impact. 
RESEARCH Conclusions
We recommend the inclusion of PMN CD64 index into the diagnostic algorithm for neonatal sepsis. A negative PMN CD64 result had a high NPV in ruling out de nite (100%) or probable and de nite infection (95.2%) at a cut-o value of 1.8. Results of PMN CD64 are available in a much shorter time than blood culture results. As the PPV of the test was low in con rming infection, PMN CD64 should be used as a screening rather than a con rmatory test for infection. A cost-e ective analysis would be of future bene t.
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